GENSPEED R2 in-vitro diagnostic system

The GENSPEED R2 analyzer is a compact, automated in vitro diagnostics system that uses microfluidics to perform rapid, multiplex testing for a variety of analytes at the point of care. It is developed and manufactured by Genspeed Biotech GmbH, a spin-off of Greiner Bio-One.

Applications and Test Kits

The GENSPEED R2 is a versatile platform used with a variety of test kits for different diagnostic purposes:

  • Hospital-Acquired Infections (HAIs): It is used with the GENSPEED MRSA test kit to rapidly detect methicillin-resistant Staphylococcus aureus (MRSA) within about 75 minutes, targeting both the mecA and mecC resistance genes.
  • C. difficile Detection: The GENSPEED C. diff OneStep R2 test kit allows for the rapid identification of toxigenic C. difficile by detecting relevant genes (GDH, toxin A, toxin B, binary toxin) in a single step.
  • Antibody Testing: It can perform semi-quantitative antibody tests, such as the GENSPEED FSME IgG xPOC test for tick-borne encephalitis (TBE).
  • Periodontitis Diagnostics: The PerioPOC Pro test system is used in dental offices for the direct detection of periodontitis pathogens via RNA-based testing, aiding in targeted treatment and prevention.
  • Other Biomarkers: The system can quantify various other biomarkers, including inflammation markers like CRP and Vitamin D.

Manufacturer: GENSPEED Biotech GmbH

Addresses:

  • Gewerbepark 2 • Gebäude B, 4261 Rainbach, Austria
  • Phone: +43 7942 20910 or +43 664 81 92 993


Product Prices:

Explicit pricing information for the GENSPEED R2 analyzer is not publicly listed online; rather, the cost is generally provided via a direct quote from the manufacturer or a distributor.


Comments

Leave a Reply

Your email address will not be published. Required fields are marked *